Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar DepressionGlobeNewsWire • 02/22/21
CAPLYTA® (lumateperone) Open-Label Safety Switching Study in Patients with Schizophrenia Published in the Journal, Schizophrenia ResearchGlobeNewsWire • 01/21/21
Do Options Traders Know Something About Intra-Cellular Therapies (ITCI) Stock We Don't?Zacks Investment Research • 01/06/21
Intra-Cellular Therapies to Present at the 39th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/05/21
Intra-Cellular Therapies Announces the Initiation of Clinical Trials for ITI-LLAI, a Long-Acting Injectable Formulation of Lumateperone for the Treatment of Schizophrenia and for ITI-333, a Novel Treatment for Opioid Use DisorderGlobeNewsWire • 12/29/20
Intra-Cellular Therapies to Present at the Evercore ISI 3rd Annual HealthCONx ConferenceGlobeNewsWire • 11/30/20
Intra-Cellular Therapies, Inc. (ITCI) CEO Sharon Mates on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/09/20
Intra-Cellular Therapies Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/09/20
Intra-Cellular Therapies to Host Third Quarter 2020 Financial Results Conference Call and WebcastGlobeNewsWire • 11/04/20
Intra-Cellular Therapies Announces the Appointment of Dr. Suresh Durgam as Chief Medical OfficerGlobeNewsWire • 10/01/20
Intra-Cellular Therapies to Present at the Cantor Virtual Global Healthcare ConferenceGlobeNewsWire • 09/14/20
Nasdaq Soars Nearly 300 Points as Intra-Cellular Breaks Through; a Lemon for Lululemon?The Motley Fool • 09/09/20
Positive Test Results For Bipolar Treatment Sends Intra-Cellular Stock SoaringInvestors Business Daily • 09/09/20
Intra-Cellular Therapies Announces Positive Topline Results from Study 402 Evaluating Lumateperone as Adjunctive Therapy in Patients with Bipolar DepressionGlobeNewsWire • 09/09/20
Implied Volatility Surging for Intra-Cellular Therapies (ITCI) Stock OptionsZacks Investment Research • 09/03/20
Intra-Cellular Therapies, Inc. (ITCI) CEO Sharon Mates on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/10/20